X

Camlin Fine Sciences Ltd. Stock Analysis

Small Cap
Evaluated by 1065 users | BSE: 532834 | NSE: CAMLINFINE |
Chemicals
Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 13.27%17.02%18.08%19.24%18.77%16.77%5.56%-0.04%3.71%6.13%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 165252314374431412325403548580
Y-o-Y Gr. Rt.-53%24.4%19.4%15%-4.3%-21.2%24.1%36.1%5.8%
Adjusted EPS (Rs.) 0.711.031.632.172.782.870.14-1.520.511.66
Y-o-Y Gr. Rt.-45.1%58.3%33.1%28.1%3.2%-95.1%-1185.7%NA225.5%
Book Value per Share (Rs.) 4.455.256.488.0810.1912.5116.7825.4926.8131.04
Adjusted Net Profit 6.69.615.320.526.627.71.5-18.46.220.1
Net Op. Cash Flow (Rs. Cr.) -8.97.913.112.926.450.9-30.1-5.2-44.673.9
Debt to Cash Flow from Ops -7.6811.078.1710.195.123.12-8.05-41.69-7.034.52
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Camlin Fine Sciences Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 15%6.1%21.3%5.8%
Adjusted EPS 9.9%-9.8%128%225.5%
Book Value per Share 24.12522.815.8
Share Price 27.6% -3.5% 2.3% 45.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 17.5521.1527.7129.8830.5325.361-7.261.825.55
Operating Profit Margin (%) 12.4814.414.5215.6614.5216.468.491.07610.42
Net Profit Margin (%) 3.983.814.875.486.186.730.46-4.571.133.47
Debt to Equity 1.651.771.771.731.381.311.390.710.960.89
Working Capital Days 181180195197200232322338305315
Cash Conversion Cycle 525062596896181180152162
Entity Percentage Holding
Promoters 22.73%
Institutions 20.73%
Non-Institutions 56.54%
Pledged *8.588.5417.2817.2820.9310.9510.8810.8810.880.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Camlin Fine Sciences Ltd.'s performance infers:

Camlin Fine Sciences Ltd. earnings have declined by -9.8%, whereas share price has depreciated -3.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Camlin Fine Sciences Ltd. share prices over the last 10 years. Here is what we found out:

Camlin Fine Sciences Ltd. share price has depreciated 28.3% annually over the past ten years.

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956. In 2011
Company changed its name from Camlin Fine Chemicals Ltd. to Camlin Fine Sciences Ltd. 

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants TBHQ and BHA. Its mission is to be the largest food antioxidant and ingredient manufacturer worldwide. Their facilities are HACCP and ISO 9001 : 2000 certified.

Product Range:

a) Food Ingredients –

Antox TBHQ (HACCP Certified) FCC V / FAO / WHO (Tertiary Butyl Hydroquinone)

Antox BHA (HACCP Certified) FCC V / FAO / WHO / EEC ( Butyl Hydroxy Anisole)

b) Sweetener -

Sucralose FCC V

c) Active Pharmaceutical Ingredients -

  • Miconazole Nitrate B.P. / USP
  • Clotrimazole B.P. / USP
  • Amlodipine Besilate E.P
  • Amlodipine Salts
  • Advance intermediate of Amlodipine
  • Intermediate of Miconazole Nitrate

d) Super Absorbent Polymer

Subsidiary Details:

  • Chemolutions Chemicals: Specialty Chemical Intermediates
  • Sangam Laboratories: Nutraceuticals
  • Fine Renewable Energy.
  • Fine LifeStyle Brands: Luxury Fashion Brands

On 6th June 2008 - The company entered into a joint venture, on 51:49 basis, with US based Viachem LLC, to set up a joint venture company under the name Dulcette Technologies for marketing Sucralose, Aspartame, and Acesulfame-K, and their belnds in USA, Canada, and Maxico.

On 7th July 2008 - The Board of Directors of the company at its meeting held on 29th July 2008, approved the proposal for setting up a joint venture company with Pagoda Advisors and their associates.

As per the deal, Camlin Fine Chemicals will get 51% of the equity of the proposed new company and the rest 49% will be owned by Pagoda Advisors and their associates.The proposed new company will focus on the retail of luxury/premium brands in India by setting up stores in all stores in all major metros and cities in India by itself and through franchisees.

On 25th February 2008:  Camlin Fine Chemicals acquired 60% equity stake in Sangam Laboratories, a Small Scale Unit manufacturing Nutraceuticals and Drug Intermediates at Tarapur.

On 12th February 2008 - The company inked a joint venture deal with US based Advanced Aerospace Technologies to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback